9 Results for "

ATPase assay

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "ATPase assay" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-147124
CAS No.: 2642218-43-5
Purity:  98.21%
Target:  

IFNAR

Research Areas:  

Infection Cancer

RIG012 is a potent RIG-I inhibitor with an IC50 of 0.71 μM using the NADH-coupled ATPase assay. RIG012 inhibits IFN-β and ISG hRsad2 expression .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-115570
CAS No.: 1644443-92-4
Purity:  ≥98.0%
Synonyms: GW108X
Target:  

Kinesin ULK Autophagy

Research Areas:  

Cancer

GW406108X is a specific Kif15 (Kinesin-12) inhibitor with an IC50 of 0.82 uM in ATPase assays. GW406108X, a potent autophagy inhibitor, shows ATP competitive inhibition against ULK1 with a pIC50 of 6.37 (427 nM). GW406108X inhibits ULK1 kinase activity and blocks autophagic flux, without affecting the upstream signaling kinases mTORC1 and AMPK .
loading...
    loading...
Cat. No.: HY-174374
CAS No.: 3076446-44-8
Target:  

Topoisomerase

Research Areas:  

Cardiovascular Disease

Topobexin is a TOP2B-selective inhibitor with IC50 values of 0.19 μM and 4.8 μM for TOP2B and TOP2A (DNA decatenation assay). Topobexin binds to non-homologous residues in the obex pocket and targets the ATPase domain of TOP2B. Topobexin prevents anthracycline-induced DNA double-strand break formation, apoptotic signaling mediated by caspase 3/7, 8 and 9, cardiomyocyte morphological changes, mitochondrial depolarization/loss, left ventricular systolic dysfunction, extracellular matrix remodeling, fibrotic alterations, and increases in plasma cardiac troponin T and BNP. Topobexin does not impair the antiproliferative effects of anthracyclines in cancer cells, exhibits no intrinsic cytotoxicity in cardiomyocytes, and is well tolerated in rabbits. Topobexin can be used in studies related to anthracycline-induced cardiotoxicity .
loading...
    loading...
Cat. No.: HY-33838
CAS No.: 18474-59-4
Research Areas:  

Others

eIF4A3-IN-8 serves as a negative control targeting eukaryotic initiation factor 4A3 (eIF4A3), with an IC50 > 100 μM; it exhibits no significant activity .
loading...
    loading...
Cat. No.: HY-158415
CAS No.: 1219577-48-6
Purity:  ≥98.0%
Research Areas:  

Cancer

ATPase-IN-4 (Compound MS1) inhibits the ATPase activity of EHD4 (IC50: 0.92 μM). ATPase-IN-4 also inhibits EHD2 enzymatic activity
loading...
    loading...
Cat. No.: HY-W107935
CAS No.: 1383133-23-0
Target:  

HSP

Research Areas:  

Cancer

Hsp90-IN-37 (Z-2) is a heat shock protein 90 (Hsp90) inhibitor that inhibits Hsp90 enzymatic activity by 69%. Hsp90-IN-37 has antitumor activity .
loading...
    loading...
Cat. No.: HY-D1560
CAS No.: 438476-80-3
FG 488 DHPE is a lipid-coupled fluorochrome, has be used as a fluorophore Oregon Green 488. FG 488 DHPE monitors acidification of lipid vesicles with λex/λem=508/534 nm.FG 488 DHPE is also used for Hv1-induced proton translocation quantificatio with λex/λem=508/534 nm as well .
loading...
    loading...
Cat. No.: HY-185458
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

DHX8-IN-1 is a DHX8 inhibitor with an IC50 of 40 nM in ATPase activity assays. DHX8-IN-1 can be used in research on DHX8-related diseases such as Dupuytren's contracture and HIV-1 infection .
loading...
    loading...
Cat. No.: HY-W1143950
CAS No.: 25840-83-9
Target:  

Kinesin

Research Areas:  

Cancer

O-Trityl-L-serine is an inhibitor of human mitotic kinesin Eg5, with a Ki app of 750 nM. O-Trityl-L-serine does not induce monopolar spindle formation or mitotic arrest in cancer cells. O-Trityl-L-serine can be used in cancer-related research .
loading...
    loading...